Preliminary Earnings Estimate for 2025
Filed with SSE · · 2 pages · Chinese
Chengdu Olymvax Biopharmaceuticals Inc. on 6ix
Earlier from Chengdu Olymvax Biopharmaceuticals
- Announcement on Shareholding Reduction Plan for Shareholders
- Announcement on Voluntary Disclosure of Obtaining the GMP Compliance Certificate from the Philippines
- Announcement on Signing a Supplementary Agreement to the Market Promotion Service Agreement for Group A and Group C Meningococcal Polysaccharide Vaccine
- Announcement on Litigation Involved
- Announcement on Completion of Shareholding Reduction Plan for Senior Management Members and Results of Shareholding Reduction
Later from Chengdu Olymvax Biopharmaceuticals
- Announcement on Requesting the General Meeting to Authorize the Board of Directors to Handle Matters Related to Issuance of Shares to Specific Objects through Summary Procedure
- Announcement on Resolutions of the 2025 Annual General Meeting
- Report for Q1 2026
- Announcement on Expiration of Shareholding Reduction Period and Result of No Share Reduction by Shareholders with over 5% Shares
- Announcement on Release of Pledge of Partial Shares Held by Shareholders with Over 5% Shares
Follow Chengdu Olymvax Biopharmaceuticals into a list and get an email when it puts out news.
Follow Chengdu Olymvax Biopharmaceuticals